456
Views
40
CrossRef citations to date
0
Altmetric
Research Articles

Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation

, , , , , , & show all
Pages 791-804 | Received 05 Feb 2016, Accepted 01 Mar 2016, Published online: 18 Apr 2016

References

  • Alder, B. J., & Wainwright, T. (1959). Studies in molecular dynamics. I. general method. The Journal of Chemical Physics, 31, 459–466.10.1063/1.1730376
  • Bhaumik, P., Gustchina, A., & Wlodawer, A. (2012). Structural studies of vacuolar plasmepsins. Biochimica et Biophysica Acta, 1824, 207–223. doi:10.1016/j.bbapap.2011.04.008
  • Cereto-Massagué, A., Guasch, L., Valls, C., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2012). DecoyFinder: An easy-to-use python GUI application for building target-specific decoy sets. Bioinformatics, 28, 1661–1662.10.1093/bioinformatics/bts249
  • Dan, N., & Bhakat, S. (2015). New paradigm of an old target: An update on structural biology and current progress in drug design towards plasmepsin II. European Journal of Medicinal Chemistry, 95, 324–348. doi:10.1016/j.ejmech.2015.03.049
  • Desmond Molecular Dynamics System. (2015). Version 4.2. D. E. Shaw Research, New York, NY.
  • Dogovski, C., Xie, S. C., Burgio, G., Bridgford, J., Mok, S., McCaw, J. M., … Tilley, L. (2015). Targeting the cell stress response of plasmodium falciparum to overcome artemisinin resistance. PLoS Biology, 13, e1002132. doi:10.1371/journal.pbio.1002132
  • Fishman, M., & Cruickshank, P. A. (1970). Febrifugine antimalarial agents. I. Pyridine analogs of febrifugine. Journal of Medicinal Chemistry, 13, 155–156.10.1021/jm00295a050
  • Gulati, M., Narula, A., Vishnu, R., Katyal, G., Negi, A., Ajaz, I., … Lumb, V. (2015). Plasmepsin II as a potential drug target for resistant malaria. DU Journal of Undergraduate Research and Innovation, 1, 57–66.
  • Hazra, S., Ghosh, S., Debnath, S., Seville, S., Prajapati, V. K., Wright, C. W., … Hazra, B. (2012). Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes. Parasitology Research, 111, 195–203.10.1007/s00436-012-2818-9
  • Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18, 1463–1472.10.1002/(ISSN)1096-987X
  • Jiang, S., Zeng, Q., Gettayacamin, M., Tungtaeng, A., Wannaying, S., Lim, A., … Fang, D. (2005). Antimalarial activities and therapeutic properties of febrifugine analogs. Antimicrobial Agents and Chemotherapy, 49, 1169–1176. doi:10.1128/AAC.49.3.1169-1176.2005
  • Keller, T. L., Zocco, D., Sundrud, M. S., Hendrick, M., Edenius, M., Yum, J., … Whitman, M. (2012). Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. Nature Chemical Biology, 8, 311–317. doi:10.1038/nchembio.790.
  • Maestro-Desmond Interoperability Tools. (2015). Version 4.4. Schrödinger, New York, NY.
  • McCarty, S. E., Schellenberger, A., Goodwin, D. C., Fuanta, N. R., Tekwani, B. L., & Calderon, A. I. (2015). Plasmodium falciparum thioredoxin reductase (PfTrxR) and its role as a target for new antimalarial discovery. Molecules, 20, 11459–11473. doi:10.3390/molecules200611459
  • McLaughlin, N. P., & Evans, P. (2009). Dihydroxylation of vinyl sulfones: stereoselective synthesis of (+)-and (−)-febrifugine and halofuginone. The Journal of organic chemistry, 75, 518–521.
  • Mishra, V. K., Mishra, M., Mishra, S., Sahu, P., & Kashaw, S. K. (2015). Febrifugine analogues: Promising antimalarial agents. Asian Journal of Pharmacy and Pharmacology, 1, 10–15.
  • Nontprasert, A., Pukrittayakamee, S., Dondorp, A. M., Clemens, R., Looareesuwan, S., & White, N. J. (2002). Neuropathologic toxicity of artemisinin derivatives in a mouse model. The American Journal of Tropical Medicine and Hygiene, 67, 423–429.
  • OLBoyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R.. (2011). Open Babel: An open chemical toolbox. Journal of Chemical Information and Modeling, 3, 33.
  • Pandey, R. K., Kumbhar, B. V., Srivastava, S., Malik, R., Sundar, S., Kunwar, A., & Prajapati, V. K. (2015). Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 1–49, doi:10.1080/07391102.2015.1135298.
  • Pandey, R. K., Sharma, D., Bhatt, T. K., Sundar, S., & Prajapati, V. K. (2015). Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. Journal of Biomolecular Structure and Dynamics, 33, 2541–2553. doi:10.1080/07391102.2015.1085904
  • Pandey, R., Sundar, S., & Prajapati, V. K. (2016). Differential expression of miRNA regulates T cell differentiation and plasticity during visceral leishmaniasis infection. Frontiers in Microbiology, 7, 206. doi:10.3389/fmicb.2016.00206.
  • Price, R., van Vugt, M., Phaipun, L., Luxemburger, C., Simpson, J., McGready, R., … Nosten, F. (1999). Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. The American Journal of Tropical Medicine and Hygiene, 60, 547–555.
  • Rajesh, T., Bagchi, P., Pande, R. K., & Mahesh, M. (2011). Comparative study and characterisation of Serine protease from Bacillus lichiniformis (MTCC) and Bacillus megaterium Electronics Computer Technology (ICECT), 2011 3rd International Conference on IEEE (Vol. 2, pp. 381–385).
  • Zhu, S., Chandrashekar, G., Meng, L., Robinson, K., & Chatterji, D. (2012). Febrifugine analogue compounds: synthesis and antimalarial evaluation. Bioorganic & Medicinal Chemistry, 20, 927–932. doi:10.1016/j.bmc.2011.11.053
  • http://www.mmv.org/malaria-medicines/malaria-treatment
  • http://www.who.int/malaria/publications/world-malaria-report-2015/en/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.